SABBY MANAGEMENT, LLC - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 28 filers reported holding PLURISTEM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$242,000
-61.5%
50,822
-14.9%
0.05%
-50.0%
Q3 2020$629,000
+139.2%
59,730
+101.1%
0.09%
+77.4%
Q2 2020$263,000
-62.7%
29,699
-84.5%
0.05%
-81.9%
Q1 2020$705,000
+217.6%
192,049
+240.3%
0.29%
+372.6%
Q4 2019$222,000
+59.7%
56,442
+51.8%
0.06%
-17.3%
Q3 2019$139,00037,1910.08%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Values First Advisors, Inc. 44,549$394,0000.39%
ARK Investment Management 1,168,616$10,331,0000.11%
MEITAV INVESTMENT HOUSE LTD 136,769$1,209,0000.07%
SABBY MANAGEMENT, LLC 29,699$263,0000.05%
ALGERT GLOBAL LLC 15,620$138,0000.05%
Shepherd Financial Partners LLC 16,730$148,0000.04%
Savior LLC 3,393$30,0000.04%
Lehman & Derafelo Financial Resources LLC 10,000$88,0000.03%
FORA Capital, LLC 8,800$78,000,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 44,470$393,0000.02%
View complete list of PLURISTEM THERAPEUTICS INC shareholders